XML 30 R8.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating Activities    
Net earnings $ 232,769 $ 176,279
Adjustments to reconcile net earnings to cash from operating activities:    
Depreciation and amortization 73,806 68,752
Share-based compensation expense 11,521 3,252
Gain on sale of businesses 0 6,551
Other, net (9,031) (17,358)
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):    
Accounts receivable, net (116,320) (25,313)
Inventories (75,421) (61,936)
Prepaid expenses and other assets (22,005) (8,654)
Accounts payable 63,766 (34,945)
Accrued compensation and employee benefits (34,894) (67,247)
Accrued expenses and other liabilities 22,945 35,021
Accrued and deferred taxes, net 30,048 14,563
Net cash provided by operating activities 177,184 75,863
Investing Activities    
Additions to property, plant and equipment (31,260) (40,172)
Acquisitions, net of cash acquired 0 (208,421)
Proceeds from sale of property, plant, and equipment 5,845 1,232
Proceeds from sale of businesses 0 16,850
Other (4,157) 0
Net Cash Provided by (Used in) Investing Activities (29,572) (230,511)
Financing Activities    
Repurchase of common stock, including prepayment under an accelerated share repurchase program (21,637) (52,916)
Change in commercial paper and notes payable 0 415,300
Dividends paid to stockholders (71,344) (70,899)
Payments to settle employee tax obligations on exercise of share-based awards (30,453) (10,019)
Other (805) (512)
Net cash used in by financing activities (124,239) 280,954
Effect of Exchange Rate on Cash and Cash Equivalents 64 (14,652)
Net (decrease) increase in cash and cash equivalents 23,437 111,654
Cash and cash equivalents at beginning of period 513,075 397,253
Cash and cash equivalents at end of period $ 536,512 $ 508,907